{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:04:55Z","timestamp":1765422295883,"version":"3.37.3"},"reference-count":45,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","award":["89221022","HYWJ201802"],"award-info":[{"award-number":["89221022","HYWJ201802"]}],"id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Clinical Medical Talents Training Funding of Shanghai","award":["89221022","HYWJ201802"],"award-info":[{"award-number":["89221022","HYWJ201802"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Oncology"],"published-print":{"date-parts":[[2022,10,11]]},"abstract":"<jats:p>Background. Melanoma is a lethal skin malignant tumor, and its formation or development is regulated by various genetic and epigenetic molecules. Although there are traditional methods provided for the doctors to evaluate the patients\u2019 prognosis or make the diagnosis, the novel method based on epigenetic markers is still needed to make the early diagnosis. Results. We identified 256 melanoma-independent prognosis-related methylation sites (<jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>P<\/a:mi>\n                     <\/a:math>\n                  <\/jats:inline-formula>\u2009&lt;\u20090.0001) and divided patients into seven methylation subgroups. Methylation levels and survival time in the C2 subgroup were lower than that of other clusters (<jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>P<\/c:mi>\n                     <\/c:math>\n                  <\/jats:inline-formula>\u2009&lt;\u20090.05). We established the predicted model of prognosis risk for melanoma using the significantly changed methylation sites in C2. The model efficiently divided patients into high- and low-risk groups (area under the receiver operating characteristic curve, 0.833). Risk scores and patient survival time were negatively correlated (rs\u2009=\u2009\u22120.325, <jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                     <\/e:math>\n                  <\/jats:inline-formula>\u2009&lt;\u20090.0001). Genes corresponding to the independent prognosis-associated methylation sites were enriched in cancer- and immunology-related pathways. We identified 35 hub genes. DOK2, GBP4, PSMB9, and NLRC5 were significantly changed according to methylation subgroups, survival, tumor stages, and T categories and were positively correlated, which was validated in the testing group (<jats:inline-formula>\n                     <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                     <\/g:math>\n                  <\/jats:inline-formula>\u2009&lt;\u20090.05). The levels of DOK2, GBP4, PSMB9, and NLRC5 had an opposite trend to their methylation sites in patients with poor prognosis. Conclusions. We identified seven DNA methylation subtypes and constructed a highly effective prognosis risk assessment model. The transcript levels of key genes corresponding to the independent prognosis-related methylation sites were significantly changed in patients according to prognosis and positively correlated with each other, indicating they may collaboratively promote melanoma formation. These findings further our understanding of the mechanism of melanoma and provide new targets for diagnosis and treatment.<\/jats:p>","DOI":"10.1155\/2022\/6608650","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T17:50:05Z","timestamp":1665510605000},"page":"1-15","source":"Crossref","is-referenced-by-count":3,"title":["Identification of Melanoma Subsets Based on DNA Methylation Sites and Construction of a Prognosis Evaluation Model"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0175-3624","authenticated-orcid":true,"given":"Li","family":"Tengda","sequence":"first","affiliation":[{"name":"School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China"},{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China"},{"name":"Zhejiang Provincial Key Laboratory for Medical Genetics, School of Laboratory Medicine and Life Science, Wenzhou Medical College, Wenzhou 325035, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-5783","authenticated-orcid":true,"given":"Qian","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7168-4735","authenticated-orcid":true,"given":"Sun","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21238984"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)31559-9"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1097\/cmr.0b013e328351fa4d"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2012.08.015"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2011.03.002"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2010.09.007"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000000198"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200309000-00012"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.013"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1655"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3130"},{"issue":"25","key":"12","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"T. J. Ley","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112304"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(09)70003-8"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102492"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.4161\/epi.23470"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts034"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1017\/s001667231200033x"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1102"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170"},{"issue":"3","key":"21","first-page":"2789","article-title":"Identification and analysis of key genes in osteosarcoma using bioinformatics","volume":"15","author":"C. Diao","year":"2018","journal-title":"Oncology Letters"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.08.61"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05608-3"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1254-4"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s147717"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00940-3"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1177\/107327480901600302"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(20000315)88:6<1484::aid-cncr29>3.0.co;2-d"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.10.006"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-017-0332-8"},{"issue":"7","key":"31","first-page":"1639","article-title":"Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma","volume":"63","author":"M. Spugnardi","year":"2003","journal-title":"Cancer Research"},{"key":"32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA methylation and cancer","volume":"70","author":"M. Kulis","year":"2010","journal-title":"Advances in Genetics"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-015-0118-4"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.112"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065x.2009.00844.x"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-2157-6"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2672"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.05.002"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6844"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1172\/jci99699"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3438"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8306"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14639-9"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz5683"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1151593"}],"container-title":["Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/jo\/2022\/6608650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jo\/2022\/6608650.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jo\/2022\/6608650.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T17:50:15Z","timestamp":1665510615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/jo\/2022\/6608650\/"}},"subtitle":[],"editor":[{"given":"Shuanglin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":45,"alternative-id":["6608650","6608650"],"URL":"https:\/\/doi.org\/10.1155\/2022\/6608650","relation":{},"ISSN":["1687-8469","1687-8450"],"issn-type":[{"type":"electronic","value":"1687-8469"},{"type":"print","value":"1687-8450"}],"subject":[],"published":{"date-parts":[[2022,10,11]]}}}